← Insider buys

NVST

Envista Holdings Corporation · Healthcare

Insiders sold $510K of Envista Holdings Corporation in the last 12 months and bought none

$0Bought, 12 mo
$510KSold, 12 mo
$3.7BMarket cap

NVST over the last year

No insider buys filed in this year

NVST after insider buys

3 months after each buy, from the first price a copier could get.

2 buys have 3 months of prices so far. A record shows here at 3.

Every filing

44 insider filings since 2021, newest first

NVSTSell

Mischa Reis · SVP, Strategy & Bus. Dev.

$220K−22.6%Aug 24
NVSTSell

Mischa Reis · SVP, Strategy, Bus. Dev.

$290K−23.0%Feb 11
NVSTBuy

Paul A Keel · CEO

$506K+8.0%Aug 14
NVSTBuy

Eric D. Hammes · CFO

$401KAug 13
NVSTSell

Howard H Yu · CFO

$380K−18.0%Mar 1
NVSTSell

Howard H Yu · CFO

$244K−9.0%Apr 20
NVSTSell

Amir Aghdaei · CEO

$544K−3.0%Mar 31
NVSTSell

Amir Aghdaei · CEO

$6.4M−25.0%Mar 22
NVSTSell

Mischa Reis · SVP, Strategy, Bus. Dev.

$505K−24.0%Mar 22
NVSTSell

Howard H Yu · CFO

$1.2M−30.0%Mar 22
NVSTSell

Amir Aghdaei · CEO

$6.3M−25.0%Mar 18
NVSTSell

Mischa Reis · SVP, Strategy, Bus. Dev.

$141K−9.0%Mar 2
NVSTSell

Curt W Bludworth · CHRO

$200K−8.0%Mar 2
NVSTSell

Howard H Yu · CFO

$172K−6.0%Mar 1
NVSTSell

Mischa Reis · SVP, Strategy, Bus. Dev.

$204K−11.0%Mar 1
NVSTSell

Curt W Bludworth · CHRO

$403K−14.0%Mar 1
NVSTSell

Mischa Reis · SVP, Strategy, Bus. Dev.

$288K−13.0%Feb 15
NVSTSell

Amir Aghdaei · CEO

$2.7M−12.0%Dec 29
NVSTSell

Mischa Reis · SVP, Strategy, Bus. Dev.

$451K−20.0%Dec 28
NVSTSell

Howard H Yu · CFO

$178K−6.0%Dec 28
NVSTSell

Curt W Bludworth · CHRO

$601K−17.0%Dec 28
NVSTSell

Amir Aghdaei · CEO

$377K−2.0%Dec 27
NVSTSell

Howard H Yu · CFO

$28K−1.0%Nov 19
NVSTSell

Mark E Nance · General Counsel

$190K−13.0%Sep 16
NVSTSell

Mark E Nance · General Counsel

$43K−3.0%Sep 7
NVSTSell

Mischa Reis · SVP, Strategy, Bus. Dev.

$426K−20.0%Aug 27
NVSTSell

Mark E Nance · General Counsel

$27K−2.0%Aug 4
NVSTSell

Jeffrey Kappler · SVP

$72K−4.0%Jul 20
NVSTSell

Curt W Bludworth · CHRO

$645K−19.0%Jun 15
NVSTSell

Mark E Nance · General Counsel

$628K−33.0%Jun 15
NVSTSell

Curt W Bludworth · CHRO

$390K−13.0%Jun 9
NVSTSell

Mischa Reis · SVP, Strategy, Bus. Dev.

$1.2M−39.0%May 11
NVSTSell

Howard H Yu · CFO

$1.6M−37.0%May 11
NVSTSell

Amir Aghdaei · CEO

$3.9M−15.0%May 10
NVSTSell

Mischa Reis · SVP, Strategy, Bus. Dev.

$46K−2.0%May 5
NVSTSell

Jeffrey Kappler · SVP

$606K−26.0%Apr 9
NVSTSell

Amir Aghdaei · CEO

$3.1M−12.0%Apr 9
NVSTSell

Howard H Yu · CFO

$77K−3.0%Apr 9
NVSTSell

Amir Aghdaei · CEO

$1.2M−5.0%Apr 7
NVSTSell

Jeffrey Kappler · SVP

$763K−32.0%Mar 30
NVSTSell

Amir Aghdaei · CEO

$28KMar 30
NVSTSell

Amir Aghdaei · CEO

$4.7M−17.0%Mar 24
NVSTSell

Howard H Yu · CFO

$996K−29.0%Mar 24
NVSTSell

Curt W Bludworth · CHRO

$498K−18.0%Feb 17
About Envista Holdings Corporation

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.